Search - tctmd.com

Displaying 1 - 20 of 101

Sort: Relevancy | Date

News Daily News

Q&A: Lior Jankelson on AI Tools for Suspected ACS and More

Todd Neale

February 10, 2026

News Daily News

FDA Approves Aficamten for Obstructive HCM

L.A. McKeown

December 29, 2025

News Daily News

Déjà Vu All Over Again? Results of Intracoronary Stem Cell Study Questioned

Yael L. Maxwell

November 13, 2025

News Opinion CV Team Dispatch

August 2025 Dispatch for the CV Team

L.A. McKeown

August 22, 2025

Presentation THT 2025

Regulatory Considerations for the Use of AI for Treating Patients With Heart Failure: The Intersection of Drugs and Devices

Presenter: Alex Cadotte

February 13, 2025

News Daily News

Acoramidis Approved in Europe for ATTR Cardiomyopathy

Michael O'Riordan

February 12, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2025

Shelley Wood

January 31, 2025

News Daily News

Societies Update Appropriate Use Criteria for Cardiac Implantable Devices

Todd Neale

January 23, 2025

News Opinion Editor's Corner

TCTMD’s Biggest News of 2024: Stories, Videos, and More

Shelley Wood

January 01, 2025

News Opinion Editor's Corner TCT 2024

What’s Going to Be Big at TCT 2024?

Michael O'Riordan

October 17, 2024

News Conference News HFSA 2024

Biomarker and Echo Data Bolster Vutrisiran’s Promise in ATTR-CM

L.A. McKeown

October 04, 2024

News Conference News HFSA 2024

‘Global Efficacy’ of Aficamten for Obstructive Disease Shown in SEQUOIA-HCM

L.A. McKeown

October 02, 2024

News Conference News ESC 2024

HELIOS-B: Novel ‘Silencer’ Agent Reduces Death, CV Events in ATTR-CM

L.A. McKeown

August 30, 2024

News Daily News

FDA Approves Dropping Aspirin for HeartMate 3 LVAD Patients

L.A. McKeown

August 21, 2024

News Daily News

FINEARTS-HF: Topline Results Support Role for Finerenone in Mildly Reduced or Preserved EF

L.A. McKeown

August 05, 2024

News Daily News

Make Way, at Last, for the Third MitraClip RCT in Functional MR: RESHAPE-HF 2

Shelley Wood

July 09, 2024

News Daily News

Vutrisiran, an siRNA for ATTR-CM, Meets Primary Endpoint in HELIOS-B

Michael O'Riordan

June 24, 2024

News Opinion CV Team Dispatch

May 2024 Dispatch for the CV Team

L.A. McKeown

May 01, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for March 2024

Shelley Wood

April 03, 2024

News Opinion Off Script

Evoque and Patisiran: A Tale of Two Regulatory Journeys

Sanjay Kaul, MD

March 29, 2024

Advertisement

Q&A: Lior Jankelson on AI Tools for Suspected ACS and More

FDA Approves Aficamten for Obstructive HCM

Déjà Vu All Over Again? Results of Intracoronary Stem Cell Study Questioned

August 2025 Dispatch for the CV Team

Regulatory Considerations for the Use of AI for Treating Patients With Heart Failure: The Intersection of Drugs and Devices

Acoramidis Approved in Europe for ATTR Cardiomyopathy

TCTMD’s Top 10 Most Popular Stories for January 2025

Societies Update Appropriate Use Criteria for Cardiac Implantable Devices

TCTMD’s Biggest News of 2024: Stories, Videos, and More

What’s Going to Be Big at TCT 2024?

Biomarker and Echo Data Bolster Vutrisiran’s Promise in ATTR-CM

‘Global Efficacy’ of Aficamten for Obstructive Disease Shown in SEQUOIA-HCM

HELIOS-B: Novel ‘Silencer’ Agent Reduces Death, CV Events in ATTR-CM

FDA Approves Dropping Aspirin for HeartMate 3 LVAD Patients

FINEARTS-HF: Topline Results Support Role for Finerenone in Mildly Reduced or Preserved EF

Make Way, at Last, for the Third MitraClip RCT in Functional MR: RESHAPE-HF 2

Vutrisiran, an siRNA for ATTR-CM, Meets Primary Endpoint in HELIOS-B

May 2024 Dispatch for the CV Team

TCTMD’s Top 10 Most Popular Stories for March 2024

Evoque and Patisiran: A Tale of Two Regulatory Journeys

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content